Seascape Capital Management Novartis Ag Transaction History
Seascape Capital Management
- $287 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,503Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.25 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$929 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$780 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$633 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...